Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 389

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

Open access
Pidala, Joseph, Kurland, Brenda, Chai, Xiaoyu, Majhail, Navneet, Weisdorf, Daniel J., Pavletic, Steven, Cutler, Corey, Jacobsohn, David, Palmer, Jeanne, Arai, Sally, Jagasia, Madan, Lee, Stephanie J.·2011·Blood

Abstract

Quality of life (QOL) after hematopoietic cell transplantation (HCT) is compromised by chronic GVHD. In a prospectively assembled multicenter cohort of adults with chronic GVHD (n = 298), we examined the relationship between chronic GVHD severity defined by National Institutes of Health (NIH) criteria and QOL as measured by the SF-36 and FACT-BMT instruments at time of enrollment. Chronic GVHD severity was independently associated with QOL, adjusting for age. Compared with population normative data, SF-36 scores were more than a SD (10 points) lower on average for the summary physical component score (PCS) and role-physical subscale, and significantly lower (with magnitude 4-10 points) for several other subscales. Patients with moderate and severe cGVHD had PCS scores comparable with scores reported for systemic sclerosis, systemic lupus erythematosus, and multiple sclerosis, and greater impairment compared with common chronic conditions including diabetes, hypertension, and chronic lung disease. Moderate to severe cGVHD as defined by NIH criteria is associated with significant compromise in multiple QOL domains, with PCS scores in the range of other systemic autoimmune diseases. Compromised QOL provides a functional assessment of the effects of chronic GVHD, and may be measured in cGVHD clinical studies using either the SF-36 or the FACT-BMT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood-2010-11-319509

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 32

  1. Buchanan, 2007, Challenges and recommendations for advancing the state-of-the-science of quality of life assessment in symptom management trials., Cancer, 110, 1621, 10.1002/cncr.22893 · DOI
  2. Halyard, 2008, Quality-of-life assessment for routine oncology clinical practice., J Support Oncol, 6, 221
  3. Lee, 2001, Recovery after stem-cell transplantation for hematologic diseases., J Clin Oncol, 19, 242, 10.1200/JCO.2001.19.1.242 · DOI
  4. Pidala, 2009, Quality of life after allogeneic hematopoietic cell transplantation., Blood, 114, 7, 10.1182/blood-2008-10-182592 · DOI · Paper page
  5. Chiodi, 2000, Quality of life in 244 recipients of allogeneic bone marrow transplantation., Br J Haematol, 110, 614, 10.1046/j.1365-2141.2000.02053.x · DOI · Paper page
  6. Fraser, 2006, Impact of chronic graft-versus-host disease on the health status of hematopoietic cell transplantation survivors: a report from the Bone Marrow Transplant Survivor Study., Blood, 108, 2867, 10.1182/blood-2006-02-003954 · DOI · Paper page
  7. Kiss, 2002, Long-term medical outcomes and quality-of-life assessment of patients with chronic myeloid leukemia followed at least 10 years after allogeneic bone marrow transplantation., J Clin Oncol, 20, 2334, 10.1200/JCO.2002.06.077 · DOI
  8. Lee, 2006, Quality of life associated with acute and chronic graft-versus-host disease., Bone Marrow Transplant, 38, 305, 10.1038/sj.bmt.1705434 · DOI · Paper page
  9. Syrjala, 1993, Recovery after allogeneic marrow transplantation: prospective study of predictors of long-term physical and psychosocial functioning., Bone Marrow Transplant, 11, 319
  10. Worel, 2002, Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngeneic stem cell transplantation., Bone Marrow Transplant, 30, 619, 10.1038/sj.bmt.1703677 · DOI
  11. Duell, 1997, Health and functional status of long-term survivors of bone marrow transplantation. EBMT Working Party on Late Effects and EULEP Study Group on Late Effects. European Group for Blood and Marrow Transplantation., Ann Intern Med, 126, 184, 10.7326/0003-4819-126-3-199702010-00002 · DOI · Paper page
  12. Lee, 2008, Recognizing and managing chronic graft-versus-host disease., Hematology Am Soc Hematol Educ Program, 134, 10.1182/asheducation-2008.1.134 · DOI · Paper page
  13. Stewart, 2004, Duration of immunosuppressive treatment for chronic graft-versus-host disease., Blood, 104, 3501, 10.1182/blood-2004-01-0200 · DOI · Paper page
  14. Socie, 1999, Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry., N Engl J Med, 341, 14, 10.1056/NEJM199907013410103 · DOI · Paper page
  15. Couriel, 2006, Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. V. Ancillary Therapy and Supportive Care Working Group Report., Biol Blood Marrow Transplant, 12, 375, 10.1016/j.bbmt.2006.02.003 · DOI · Paper page
  16. Pavletic, 2006, Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. IV. Response Criteria Working Group report., Biol Blood Marrow Transplant, 12, 252, 10.1016/j.bbmt.2006.01.008 · DOI · Paper page
  17. Schultz, 2006, Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. III. Biomarker Working Group Report., Biol Blood Marrow Transplant, 12, 126, 10.1016/j.bbmt.2005.11.010 · doi:10.1016/j.bbmt.2005.11.010
  18. Shulman, 2006, Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. II. Pathology Working Group Report., Biol Blood Marrow Transplant, 12, 31, 10.1016/j.bbmt.2005.10.023 · DOI · Paper page
  19. Filipovich, 2005, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-Versus-Host Disease. I. Diagnosis and Staging Working Group report., Biol Blood Marrow Transplant, 11, 945, 10.1016/j.bbmt.2005.09.004 · DOI · Paper page
  20. Martin, 2006, National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease. VI. Design of Clinical Trials Working Group report., Biol Blood Marrow Transplant, 12, 491, 10.1016/j.bbmt.2006.03.004 · doi:10.1016/j.bbmt.2006.03.004
  21. McHorney, 1993, The MOS 36-Item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs., Med Care, 31, 247, 10.1097/00005650-199303000-00006 · DOI · Paper page
  22. Ware, 1994, SF-36 Physical and Mental Health Summary Scales: A User's Manual
  23. Ware, 1993, SF-36 Health Survey: Manual and Interpretation Guide
  24. Ware JE, 2000, How to Score Version 2 of the SF-36 Health Survey
  25. Obuchowski, 2005, Estimating and comparing diagnostic tests' accuracy when the gold standard is not binary., Acad Radiol, 12, 1198, 10.1016/j.acra.2005.05.013 · DOI
  26. Nguyen, 2007, nonbinROC: software for evaluating diagnostic accuracies with non-binary gold standards., J Stat Softw, 21, 1, 10.18637/jss.v021.i10 · doi:10.18637/jss.v021.i10
  27. Alarcon, 2004, Systemic lupus erythematosus in a multiethnic lupus cohort (LUMINA). XVII. Predictors of self-reported health-related quality of life early in the disease course., Arthritis Rheum, 51, 465, 10.1002/art.20409 · DOI · Paper page
  28. Del Rosso, 2004, Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers., Arthritis Rheum, 51, 475, 10.1002/art.20389 · DOI
  29. Khanna, 2005, Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study., Arthritis Rheum, 52, 592, 10.1002/art.20787 · DOI
  30. Mahler, 1995, Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD., Chest, 107, 1585, 10.1378/chest.107.6.1585 · DOI · Paper page
  31. Pittock, 2004, Quality of life is favorable for most patients with multiple sclerosis: a population-based cohort study., Arch Neurol, 61, 679, 10.1001/archneur.61.5.679 · DOI
  32. Mitchell, 2010, Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)., Bone Marrow Transplant, 45, 762, 10.1038/bmt.2009.238 · DOI

Cited by

See all 389

Metadata

Authors
Pidala, J., Kurland, B., Chai, X., Majhail, N., Weisdorf, D. J., Pavletic, S., Cutler, C., Jacobsohn, D., Palmer, J., Arai, S., Jagasia, M., & Lee, S. J.
Venue
Blood
Published
2011-04-28
Volume
117
Issue
17
Pages
4651-4657
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2005604237
Cited by
389
References
1
FWCI
14.90
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. https://app.cochat.ai/papers/10.1182/blood-2010-11-319509
The paper
Pidala, J., Kurland, B., Chai, X., Majhail, N., Weisdorf, D. J., Pavletic, S., Cutler, C., Jacobsohn, D., Palmer, J., Arai, S., Jagasia, M., & Lee, S. J. (2011). Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium. Blood. https://doi.org/10.1182/blood-2010-11-319509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.